sales@angenesci.com
Login | Register
logo
Structures Search
Home Carboxys (6R,7R)-7-{2-[2-(aminomethyl)phenyl]acetamido}-3-({[1-(carboxymethyl)-1H-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-{2-[2-(aminomethyl)phenyl]acetamido}-3-({[1-(carboxymethyl)-1H-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

CAS No.:
60925-61-3
Catalog Number:
AG00E90B
Molecular Formula:
C20H21N7O6S2
Molecular Weight:
519.5540
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
96%
In Stock USA
United States
$140
- +
1g
96%
In Stock USA
United States
$363
- +
5g
96%
In Stock USA
United States
$1225
- +
Product Description
Catalog Number:
AG00E90B
Chemical Name:
(6R,7R)-7-{2-[2-(aminomethyl)phenyl]acetamido}-3-({[1-(carboxymethyl)-1H-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number:
60925-61-3
Molecular Formula:
C20H21N7O6S2
Molecular Weight:
519.5540
MDL Number:
MFCD00210833
IUPAC Name:
(6R,7R)-7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
InChI:
InChI=1S/C20H21N7O6S2/c21-6-11-4-2-1-3-10(11)5-13(28)22-15-17(31)27-16(19(32)33)12(8-34-18(15)27)9-35-20-23-24-25-26(20)7-14(29)30/h1-4,15,18H,5-9,21H2,(H,22,28)(H,29,30)(H,32,33)/t15-,18-/m1/s1
InChI Key:
SLAYUXIURFNXPG-CRAIPNDOSA-N
SMILES:
NCc1ccccc1CC(=O)N[C@@H]1C(=O)N2[C@@H]1SCC(=C2C(=O)O)CSc1nnnn1CC(=O)O
UNII:
8M1YF8951V
Properties
Complexity:
905  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
519.099g/mol
Formal Charge:
0
Heavy Atom Count:
35  
Hydrogen Bond Acceptor Count:
12  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
519.551g/mol
Monoisotopic Mass:
519.099g/mol
Rotatable Bond Count:
10  
Topological Polar Surface Area:
244A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-3.2  
Literature
Title Journal
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ (Clinical research ed.) 20100101
Chemoprophylactic and bactericidal efficacy of 80 mg gentamicin in a single and once-daily dosing. Archives of gynecology and obstetrics 20050901
Primary lymphocutaneous nocardiosis in an immunocompetent patient. Annals of clinical microbiology and antimicrobials 20040101
The pharmacokinetics of the interstitial space in humans. BMC clinical pharmacology 20030101
The in vitro activity of beta-lactamase inhibitors in combination with cephalosporins against M. tuberculosis. Proceedings of the National Science Council, Republic of China. Part B, Life sciences 19950401
In vitro susceptibilities of Mycobacterium tuberculosis to 10 antimicrobial agents. Antimicrobial agents and chemotherapy 19880901
Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages. Tubercle 19880301
Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 19871001
Treatment of scleroma with ceforanide. Archives of otolaryngology--head & neck surgery 19870401
Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods. Antimicrobial agents and chemotherapy 19850101
Ceforanide: antibacterial activity, pharmacology, and clinical efficacy. Pharmacotherapy 19820101
Control of phenylalanine hydroxylase synthesis in tissue culture by serum and insulin. Journal of cellular physiology 19760101
Properties